Opo Bio Introduces Porcine Cell Range Sourced From New Zealand “High-Health Status” Livestock
Opo Bio, New Zealand’s first company to develop non-GM cell lines for the cultivated meat industry, has launched Opo-Oink, a porcine cell range for cultivated pork production. The initial selection of Opo-Oink includes primary cells from pigs, such as satellite cells, pre-adipocytes, and fibroblasts, sourced from local livestock with high-health status. “At Opo, we believe in ethical standards and traceability. That’s why all our animal donors are raised with utmost care and integrity on our partner farms throughout Aotearoa, New Zealand,” says Opo Bio. Commercially available cell lines Opo Bio was founded in July 2022 by Dr. Olivia Ogilvie (CEO), Dr. Laura Domigan (CSO), and Dr. Vaughan Feisst (CTO) to develop primary cells and cell lines, starting with bovine and porcine products. According to the …